FIGURE 3.

Metered‐dose inhaler (MDI) proportion by low‐dose combination device recommendation in guidance. Point estimate and distribution in MDI prescription proportion for 2 groups; clinical commissioning group (CCGs) that did have low‐dose combination dry powder inhalers (DPIs) included first‐line, and those that did not. Prescription data include all indications for inhalers (including asthma and chronic obstructive pulmonary disease) but excludes salbutamol relievers. For each group, the blue box represents the interquartile range, the black bar shows the median value and the whiskers show 1.5× interquartile range outside of the first and third quartiles. Data points outside this range are shown as unfilled circles, each representing 1 CCG. There was no significant difference between the 2 groups (Mann–Whitney U = 810, P = .42).